Photon Counting Computed Tomography Market Size To Reach USD 619.9 Million In 2033

2026-03-26 05:11:37

(MENAFN- Market Press Release) March 25, 2026 2:18 am - The Photon Counting Computed Tomography market, valued at USD 87.3 million in 2025, is expected to register revenue CAGR of 27.7%. Request free copy of this report:

March 25, 2026- The increasing prevalence of chronic diseases is a major factor driving market revenue growth. According to the Centres for Disease Control and Prevention, heart disease remains the leading cause of death in the United States across men, women, and most racial and ethnic groups. Cardiovascular disease results in one death every 34 seconds, accounting for 919,032 deaths in 2023-nearly one in every three fatalities. Additionally, individuals under the age of 65 represented approximately one in six deaths related to cardiovascular diseases (CVDs) during the same year.

In March 2025, Siemens Healthineers received FDA clearance for its Naeotom Alpha range of photon-counting CT scanners. This portfolio now includes the Naeotom Alpha, the second dual-source CT system, and the Naeotom Alpha, recognized as the first single-source photon-counting CT scanner globally. The original dual-source system, now renamed Naeotom Alpha, continues to serve as the flagship model within the Naeotom Alpha lineup.

However, one of the major limitations of photon-counting CT (PCCT) technology is its high cost, both in terms of initial investment and ongoing maintenance. The development of advanced semiconductor detectors, cooling systems, and high-speed electronics significantly increases costs compared to conventional CT scanners. As a result, adoption remains limited to a small number of hospitals, where these systems are primarily used for research or specialized applications. This restricts widespread accessibility and slows broader clinical validation in general healthcare settings.

Want to Know What's Fueling the Photon Counting Computed Tomography Market Growth? Get Exclusive Report Insights Here:

Segments market overview and growth Insights
Based on technology, photon counting computed tomography market is segmented into photon counting CT systems, spectral CT/multienergy CT systems, and hybrid photon counting solutions. Photon counting CT systems segment contributed the largest revenue share in 2025. Photon-counting CT (PCCT) enables precise differentiation between tissue types and contrast agents through spectral imaging, delivering enhanced virtual non-contrast images and accurate material quantification within each voxel (such as calcium and iodine). This capability improves the accuracy of applications including perfusion and ventilation assessment, kidney stone analysis, and other diagnostic evaluations. These benefits arise from the unique characteristics of photon-counting detectors (PCDs), which use semiconductor materials to directly convert incoming photons into electrical signals.

Regional market overview and growth insights
North America held the largest market share in 2025. Market growth is primarily driven by the increasing prevalence of cancer and cardiovascular diseases, along with advancements in detector materials and computing technologies. Lung cancer remains the leading cause of cancer-related deaths globally. In the United States, approximately 226,650 new cases are expected to be diagnosed by 2025. Statistically, about one in 16 individuals will develop lung cancer during their lifetime, including one in 17 women and one in 16 men. Smoking continues to be the dominant risk factor, contributing to nearly 80% of lung cancer-related deaths.

Competitive Landscape and Key Competitors
The photon counting computed tomography market is characterized by a consolidated structure, with few players competing across various segments and regions. List of major players included in the photon counting computed tomography market report are:

oSiemens Healthineers AG
oGE HealthCare
oCanon Medical Systems Corporation
oKromek Group plc
oNeuroLogica Corp.
oNeusoft Medical Systems
oDunlee (Koninklijke Philips N.V.)
oDetection Technology Plc

Buy Your Exclusive Copy Now:

Major strategic developments by leading competitors
Neusoft Medical Systems: In August 2025, the National Medical Products Administration approved Neusoft Medical Systems' NeuViz P10 photon-counting CT for commercial use, marking the first approval of a photon-counting CT system in China. It is also recognized as the world's first wide-body system featuring an 8-cm detector. This technology enables faster scanning, enhanced patient safety, intelligent workflow support, and opens new opportunities for clinical research.

NeuroLogica Corp.: In January 2023, NeuroLogica Corp., a subsidiary of Samsung Electronics, announced a collaboration with the University of Dundee in the United Kingdom to conduct research using the OmniTom Elite system equipped with photon-counting detector (PCD) CT imaging technology.

Unlock the Key to Transforming Your Business Strategy with Our Photon Counting Computed Tomography Market Insights –
.Download the report summary:
.Request customization:

Navistrat Analytics has segmented the photon counting computed tomography market based on detector type, technology, application, end-use, and region:
.Detector Type Outlook (Revenue, USD Million; 2023-2033)
oSilicon-Based Photon Counting Detectors
oCadmium Telluride (CdTe) Detectors
oCadmium Zinc Telluride (CZT) Detectors
oGallium Arsenide (GaAs) Detectors
oOthers

.Technology Outlook (Revenue, USD Million; 2023-2033)
oPhoton Counting CT Systems
oSpectral CT / Multienergy CT Systems
oHybrid Photon Counting Solutions

.Application Outlook (Revenue, USD Million; 2023-2033)
oClinical Applications
oResearch Applications

.End-Use Outlook (Revenue, USD Million; 2023-2033)
oHospitals
oDiagnostic Imaging Centers
oResearch & Academic Institutions
oGovernment and Defense Healthcare Facilities

.Regional Outlook (Revenue, USD Million; 2023-2033)
oNorth Benelux
g Countries
h of Europe
oAsia Pacific
a Japan
d Oceania
f Countries
g of APAC
oLatin Brazil
b of LATAM
oMiddle East & Africa
a Countries
b Turkey
e of MEA

Get a preview of the complete research study:

About Us:
At Navistrat Analytics, we provide high-quality, comprehensive syndicated and customized market research reports that deliver actionable insights and empower businesses through data-driven strategies. Choose Navistrat Analytics as your strategic growth partner for reliable market intelligence, and let us help you navigate the complexities of the market with clarity, precision, and confidence.

MENAFN26032026003520003262ID1110909182

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.